Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Gagnon Securities LLC

Gagnon Securities LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 59,161 shares of the medical equipment provider’s stock after selling 2,909 shares during the period. Intuitive Surgical makes up approximately 6.2% of Gagnon Securities LLC’s investment portfolio, making the stock its 2nd biggest position. Gagnon Securities LLC’s holdings in Intuitive Surgical were worth $30,880,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. raised its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the third quarter worth $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 28,843 shares of company stock valued at $15,357,560 in the last three months. 0.90% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on ISRG. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $571.88 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The company has a market capitalization of $203.69 billion, a P/E ratio of 89.22, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39. The company has a 50-day simple moving average of $549.92 and a 200 day simple moving average of $508.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.